For instance, the spectrum of NR5A1 mutations presented in our 46,XY cohort as CGD (two patients), PGD (four patients), hypospadias (one patient) and DASA (one patient); additionally, it has also been shown to include spermatogenic failure [46]. This evidence concerns the gene NR5A1 and spermatogenic failure.